Longer-form thinking on responsible implementation and the intersection of domain expertise with AI capability. More frequent notes live on LinkedIn.
Five verdicts from two days at the World EPA Congress AI & Digital Transformation track — what's actually working, what's failing, and where the implementation gaps are for pharmaceutical organisations deploying AI in HEOR, pricing and market access contexts.
With ChatGPT and Claude integrating directly into analytical workflows, we're entering new territory in Market Access and HEOR. But when convenience becomes over-reliance, something subtle but significant can be lost.
Read on LinkedIn →The EU's prescriptive framework contrasts sharply with the UK's principles-based approach and the US's fragmented state-by-state system. Understanding these philosophies isn't just compliance — it's strategic planning.
Read on LinkedIn →A reference guide that helped me consolidate my learning in AI & Digital Transformation — fundamentals through to current systems, with a search function for quick lookup. Deployed publicly in case it's useful to others.
Read on LinkedIn →Tracking EU AI Act implementation, UK principles-based approaches and US state-level legislation — and how different regulatory philosophies shape strategy for organisations in multiple markets.
The most valuable AI consultants bridge domain knowledge with AI understanding. Maintaining scientific rigour while adopting AI; communicating AI-driven insight to payers, clinicians and regulators.
Documenting the MA journey openly — projects, insights and lessons. Each post and project compounds over time into a track record of public work.
